Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease

Kathleen M. Hill, Berdine R. Martin, Meryl E. Wastney, George P. McCabe, Sharon M. Moe, Connie M. Weaver, Munro Peacock

Research output: Contribution to journalArticle

152 Scopus citations

Abstract

Patients with chronic kidney disease (CKD) are given calcium carbonate to bind dietary phosphorus, reduce phosphorus retention, and prevent negative calcium balance; however, data are limited on calcium and phosphorus balance during CKD to support this. Here, we studied eight patients with stage 3 or 4 CKD (mean estimated glomerular filtration rate 36 ml/min) who received a controlled diet with or without a calcium carbonate supplement (1500 mg/day calcium) during two 3-week balance periods in a randomized placebo-controlled cross-over design. All feces and urine were collected during weeks 2 and 3 of each balance period and fasting blood, and urine was collected at baseline and at the end of each week. Calcium kinetics were determined using oral and intravenous 45 calcium. Patients were found to be in neutral calcium and phosphorus balance while on the placebo. Calcium carbonate supplementation produced positive calcium balance, did not affect phosphorus balance, and produced only a modest reduction in urine phosphorus excretion compared with placebo. Calcium kinetics demonstrated positive net bone balance but less than overall calcium balance, suggesting soft-tissue deposition. Fasting blood and urine biochemistries of calcium and phosphate homeostasis were unaffected by calcium carbonate. Thus, the positive calcium balance produced by calcium carbonate treatment within 3 weeks cautions against its use as a phosphate binder in patients with stage 3 or 4 CKD, if these findings can be extrapolated to long-term therapy.

Original languageEnglish (US)
Pages (from-to)959-966
Number of pages8
JournalKidney international
Volume83
Issue number5
DOIs
StatePublished - May 2013

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease'. Together they form a unique fingerprint.

  • Cite this

    Hill, K. M., Martin, B. R., Wastney, M. E., McCabe, G. P., Moe, S. M., Weaver, C. M., & Peacock, M. (2013). Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease. Kidney international, 83(5), 959-966. https://doi.org/10.1038/ki.2012.403